New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
09:03 EDTGALTGalectin Therapeutics receives FDA approval to proceed with human clinical trial
Galectin Therapeutics announced that following review of its Investigational New Drug application, the FDA notified the company that it may proceed with a Phase 1 clinical trial. The first-in-man Phase 1 clinical trial will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis with advanced fibrosis.
News For GALT From The Last 14 Days
Check below for free stories on GALT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
08:07 EDTGALTGalectin Therapeutics issued U.S. patent for GR-MD-02
Subscribe for More Information
September 12, 2014
15:12 EDTGALTGalectin Therapeutics says in ongoing talks with large pharma companies
Subscribe for More Information
September 11, 2014
07:25 EDTGALTAegis to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use